Djibouti vs Philippines: Access to anti-retroviral drugs, female
Djibouti
23.0%
in 2024
Philippines
21.0%
in 2024
Djibouti rank
137th
Philippines rank
138th
Access to anti-retroviral drugs, female over time
- Djibouti
- Philippines
How they compare
Djibouti currently reports 23.0% against 21.0% in Philippines, a difference of 2.0%.
That makes Djibouti's figure about 1.1 times Philippines's.
The two have swapped places 7 times across 24 shared years of data; in 2000 it was Philippines ahead.
Djibouti ranks 137th and Philippines ranks 138th of 141 countries.
Across the 3 decades both report, Djibouti averaged higher in 2 and Philippines in 1.
Head to head by decade
| Decade | Djibouti | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.8% | 3.9% | 1.1% | Philippines |
| 2010s | 17.7% | 13.2% | 4.5% | Djibouti |
| 2020s | 23.8% | 21.0% | 2.8% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Djibouti or Philippines?
- Djibouti, at 23.0% against 21.0% in Philippines as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Djibouti and Philippines?
- 2.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Philippines?
- 24 years are reported by both, from 2000 to 2024.
- How do Djibouti and Philippines rank globally for access to anti-retroviral drugs, female?
- Djibouti ranks 137th and Philippines ranks 138th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.